Quick answer: The skin is not a passive barrier but an immunologically active organ in continuous crosstalk with the gut, liver, endocrine system, and microbiome. Acne, psoriasis, atopic dermatitis, and rosacea are not skin diseases — they are systemic inflammatory conditions with cutaneous expression. The gut-skin axis, operating through intestinal permeability, microbial metabolites, systemic cytokines, and hormonal signaling, explains why the most intractable skin diseases respond poorly to topical treatments and dramatically to root-cause metabolic and gastrointestinal interventions. Functional dermatology identifies and addresses the upstream drivers that conventional dermatology largely ignores.
The Gut-Skin Axis: Mechanisms of Bidirectional Communication
The gut-skin axis is a bidirectional communication network operating through immune, endocrine, and neural channels. The gut houses 70-80% of the body’s immune cells, primarily in gut-associated lymphoid tissue (GALT). Antigens breaching the intestinal barrier — whether bacterial fragments, undigested food proteins, or microbial metabolites — activate systemic immune responses that manifest in the skin. The skin itself contains approximately 2 million T-cells and a resident microbiome of over 1,000 bacterial species (Grice 2011 Nature Reviews Microbiology), which maintain barrier function and educate local immune cells.
Short-chain fatty acids (SCFAs) — butyrate, propionate, and acetate — produced by colonic fermentation of dietary fiber regulate skin barrier function through histone deacetylase (HDAC) inhibition and regulatory T-cell induction. Butyrate, the primary colonocyte fuel, suppresses NFκB-mediated inflammation systemically, explains why low-fiber Western diets correlate with inflammatory skin disease. Strandwitz 2016 (Nature Microbiology) demonstrated that Faecalibacterium prausnitzii — the most abundant butyrate-producing commensal, dramatically depleted in psoriasis and atopic dermatitis patients — produces butyrate specifically through cross-feeding relationships requiring other Bacteroides species. Dysbiosis disrupting this syntrophic network collapses butyrate production and removes a systemic anti-inflammatory brake.
Acne Vulgaris: The Metabolic and Hormonal Root Causes
mTORC1 Signaling and the Western Diet
Bodo Melnik’s research has reframed acne vulgaris as a disease of chronic mTORC1 (mechanistic Target Of Rapamycin Complex 1) hyperactivation — the same nutrient-sensing pathway implicated in aging and metabolic disease. mTORC1 is activated by: leucine from high-animal-protein diets, IGF-1 from cow’s milk, and insulin from refined carbohydrates. When activated in sebocytes (sebaceous gland cells) and keratinocytes, mTORC1 simultaneously increases sebum production (via upregulation of SREBP-1c lipogenic transcription factor), promotes keratinocyte proliferation causing follicular hyperkeratosis (comedone formation), and triggers lipid peroxidation creating the oxidized sebum that Cutibacterium acnes metabolizes to produce proinflammatory fatty acids. Melnik 2015 (Dermato-Endocrinology) demonstrated that all three primary acne-promoting pathways — hyperandrogenism, hyperinsulinemia, and milk-derived IGF-1 — converge on mTORC1, explaining the dietary-acne connection that placebo-controlled trials confirm.
Milk’s acnegenic potential extends beyond its IGF-1 and leucine content. Adebamowo et al. (2005 Journal of the American Academy of Dermatology, 47,355 nurses) found significant positive associations between milk intake and acne, with skim milk showing the strongest association (OR 1.44 for two or more servings/day) — despite skim milk having lower fat and lower energy density than whole milk. The association is attributed to milk’s whey proteins (rapidly absorbed amino acids that spike insulin and IGF-1), bioactive peptides derived from casein hydrolysis, and milk’s estrogen and progesterone precursor content that survives pasteurization and activates androgen signaling in sebocytes. Eliminating dairy from the diet produces clinical improvement in the majority of acne patients in practice.
Androgen Physiology and Sebaceous Activity
Sebaceous glands are exquisitely sensitive to androgens — both testosterone and its more potent 5α-reduced metabolite dihydrotestosterone (DHT) stimulate sebocyte proliferation and sebum production via androgen receptor activation. Insulin resistance amplifies this pathway by suppressing hepatic SHBG production (reducing protein-bound, biologically inactive testosterone) and increasing ovarian androgen output (the PCOS mechanism) while simultaneously activating IGF-1-driven 5α-reductase expression. This explains the clinical observation that women with PCOS have dramatically elevated acne rates — not simply from elevated testosterone, but from the combined metabolic disruption of hyperinsulinemia, elevated free androgens, and mTORC1 activation. Addressing insulin resistance in acne patients — through low-glycemic diet, berberine, inositol, or metformin in PCOS-associated acne — treats the root hormonal dysregulation that topical retinoids and antibiotics do not touch.
The Gut Microbiome in Acne Pathogenesis
The acne microbiome literature reveals not merely altered skin microbiome but profoundly disrupted gut ecology. Kim 2018 (PLOS ONE) compared gut microbiome composition in acne patients vs. healthy controls and found reduced Lactobacillus, Bifidobacterium, and Faecalibacterium prausnitzii with increased Clostridiales and gram-negative taxa. Gut-derived LPS activating systemic TLR-4 receptors in sebocytes increases sebum production and inflammatory cytokine release. Oral probiotics — particularly Lactobacillus rhamnosus SP1 — demonstrated significant reduction in acne lesion count and improved IGF-1/IGFBP-3 ratio in a 12-week randomized trial (Fabbrocini 2016 Beneficial Microbes), mediated through IGFBP-3 upregulation that reduces free IGF-1 available to mTORC1 signaling in sebocytes. This gut-to-skin hormonal axis represents a uniquely functional dermatology treatment target.
Psoriasis: The Immune Dysregulation and Metabolic Connection
Psoriasis as a Systemic Inflammatory Disease
Psoriasis affects 2-3% of the global population and is now recognized as a systemic inflammatory condition, not a localized skin disease. The pathological immune axis — Th17 lymphocytes producing IL-17A driving keratinocyte hyperproliferation — is shared with several autoimmune conditions, explaining psoriatic arthritis (affecting 30% of psoriasis patients), uveitis, and the dramatically elevated cardiovascular risk in psoriasis patients. Mehta 2011 (Journal of the American Medical Association, 130,976 patients) demonstrated that severe psoriasis independently conferred a 58% increased risk of major cardiovascular events after adjustment for traditional risk factors — attributable to shared TNF-α, IL-6, and IL-17 pathways driving endothelial dysfunction, insulin resistance, and atherosclerosis.
Intestinal Permeability and Psoriasis
Multiple studies confirm intestinal hyperpermeability in psoriasis patients. Fasano’s group and others have measured elevated serum zonulin — the master regulator of tight junction permeability — in psoriasis, correlating with disease severity scores (PASI). The psoriasis gut microbiome shows consistently reduced Akkermansia muciniphila (the mucus-degrading commensal that paradoxically strengthens the mucus layer through its metabolic byproducts), reduced Faecalibacterium prausnitzii, and increased Candida colonization. Candida-derived β-glucan activates NLRP3 inflammasome and promotes Th17 differentiation — directly amplifying the psoriatic immune axis. Patients on conventional biologics (anti-TNF, anti-IL-17, anti-IL-23) often achieve incomplete responses or develop secondary resistance; addressing concurrent intestinal permeability, dysbiosis, and metabolic comorbidities frequently improves biologic response.
Dietary Interventions in Psoriasis
The evidence for dietary intervention in psoriasis has matured substantially. Naldi et al. (2009 British Journal of Dermatology) in a 1,900-patient observational study found Mediterranean diet adherence inversely correlated with psoriasis severity independently of BMI, alcohol, and smoking. Weight loss in overweight psoriasis patients produces significant PASI score improvements — a 2019 NEJM study (Jensen 2019) showed that a calorie-restricted weight loss intervention combined with secukinumab (anti-IL-17 biologic) achieved 20% greater skin clearance than secukinumab alone. The omega-3 mechanism is particularly well-characterized: EPA competes with arachidonic acid for COX and LOX enzyme active sites, reducing prostaglandin E2 and leukotriene B4 synthesis that amplifies IL-17 secretion. Randomized trials of omega-3 supplementation (3-6g EPA/DHA/day) consistently show modest but significant psoriasis severity reduction. Gluten elimination is evidence-based specifically in psoriasis patients with elevated anti-gliadin antibodies — a subgroup demonstrably benefiting from gluten elimination (Michaelsson 2000 Lancet).
Atopic Dermatitis: The Barrier Defect, Th2 Dominance, and Microbiome
Filaggrin Mutations and Skin Barrier Dysfunction
Atopic dermatitis (eczema) affects 15-20% of children and 5-10% of adults globally, with incidence rising in industrialized nations. The “inside-out” hypothesis — that atopic dermatitis begins with skin barrier dysfunction that allows allergen penetration and Th2 sensitization — is supported by filaggrin (FLG) loss-of-function mutations in 25-50% of European AD patients. Filaggrin is a structural protein essential for stratum corneum integrity; its deficiency produces the “leaky skin” that exposes immune cells to environmental allergens, house dust mite proteases, and microbial antigens. FLG mutations are the single strongest genetic risk factor for atopic dermatitis, with 60-80% of FLG-null individuals developing AD by age 3. However, FLG mutations are present in only half of AD patients, and environmental factors — early antibiotic use, cesarean delivery, formula feeding, reduced microbial diversity in early life (“hygiene hypothesis”) — strongly predict AD development independently of genetics.
Staphylococcus aureus Dominance and the Skin Microbiome
The atopic skin microbiome is characterized by near-monoculture dominance of Staphylococcus aureus — which colonizes 90% of AD lesional skin (vs. 5% of healthy skin). S. aureus produces multiple virulence factors directly pathogenic in AD: serine proteases that cleave filaggrin and desmoglein-1 (worsening barrier disruption), δ-toxin that degranulates mast cells triggering histamine release and itch, superantigens (TSST-1, staphylococcal enterotoxin B) that non-specifically activate T-cells amplifying Th2 cytokine production (IL-4, IL-5, IL-13), and protein A that inhibits filaggrin gene expression. Restoring skin microbiome diversity — through dilute bleach baths (0.005% sodium hypochlorite, 10 minutes 3x/week, which reduces S. aureus colonization without damaging commensal diversity), emollient barriers improving filaggrin function, and potentially commensal transplantation from healthy siblings — addresses the dysbiotic driver that topical steroids suppress but do not resolve.
Vitamin D Deficiency and Atopic Dermatitis
Vitamin D has immunomodulatory effects directly relevant to atopic dermatitis: it induces cathelicidin (LL-37) expression — an endogenous antimicrobial peptide — in keratinocytes, reducing S. aureus colonization. It also promotes regulatory T-cell differentiation, shifting the Th2 immune skewing characteristic of AD toward a more balanced Th1/Treg profile. Multiple studies document vitamin D deficiency (25-OH vitamin D below 30 ng/mL) in AD patients at significantly higher rates than controls. Randomized trials of vitamin D supplementation in AD produce modest but consistent improvements: Camargo et al. (2014 Journal of Allergy and Clinical Immunology) found vitamin D3 1,000 IU/day for 1 month significantly reduced SCORAD (AD severity) vs. placebo in children with winter-pattern worsening. Targeting 60-70 ng/mL serum vitamin D provides optimal antimicrobial and immune regulatory effects that the conventional sufficient threshold of 30 ng/mL does not achieve.
Rosacea: The Vascular, Neural, and Microbial Triangle
Demodex Folliculorum, SIBO, and Rosacea Pathogenesis
Rosacea affects 5-10% of the global population and is conventionally managed with topical metronidazole, azelaic acid, and oral doxycycline — without addressing the upstream drivers that sustain the condition. Two pathogenic factors with robust evidence deserve functional medicine attention. First, Demodex folliculorum mites — present on normal facial skin at low densities — are found at 10-18 fold higher densities on rosacea skin (Forton 2005 Journal of the European Academy of Dermatology). When Demodex dies, it releases its bacterial endosymbiont Bacillus oleronius, which triggers an innate immune response via TLR-2 activation; patients with rosacea show elevated anti-Bacillus oleronius antibody titers proportional to Demodex density. Topical ivermectin (Soolantra) directly targets Demodex and achieves superior clearance vs. metronidazole specifically in Demodex-dense rosacea.
Second, a landmark study by Parodi et al. (2008 Clinical Gastroenterology and Hepatology) found SIBO (small intestinal bacterial overgrowth) in 46% of rosacea patients vs. 5% of controls. Eradication of SIBO with rifaximin produced complete resolution of rosacea lesions in 20 of 28 treated patients (71%) and significant improvement in the remainder — durable at 9-month follow-up. The mechanism: SIBO-derived LPS and bacterial metabolites increase intestinal permeability and systemic endotoxemia, activating facial TLR-2-mediated inflammation. Hydrogen SIBO (Lactulose breath testing) has the highest sensitivity; elemental diet, rifaximin, or herbal antimicrobials (oil of oregano, berberine, allicin) followed by prokinetic therapy to prevent SIBO recurrence represents a rational gut-directed approach to treatment-resistant rosacea.
Cathelicidin, KLK5, and the Innate Immune Dysregulation
Rosacea skin demonstrates abnormally elevated levels of cathelicidin LL-37 and the serine protease kallikrein 5 (KLK5) that activates it. Cathelicidin fragments produced by excessive KLK5 activity trigger mast cell degranulation, neovascularization via VEGF induction, and TRP (transient receptor potential) channel sensitization that explains the neurosensory hypersensitivity characteristic of rosacea — flushing from temperature, alcohol, spicy food, emotional stress, and exercise. Niacinamide (nicotinamide, B3) suppresses cathelicidin production in keratinocytes and has demonstrated clinical efficacy in papulopustular rosacea in small trials. Zinc supplementation reduces KLK5 activity. Reduction of dietary triggers activating mast cells — histamine, alcohol, spicy foods — requires addressing the histamine intolerance frequently comorbid with SIBO that amplifies the rosacea vasoreactive response.
The Skin Microbiome: Friend, Foe, and Functional Target
The skin microbiome — 2 million T cells and over 1,000 bacterial species per cm² — performs functions as essential as the gut microbiome: barrier maintenance, antimicrobial peptide induction, immune cell education, and competitive exclusion of pathogens. Staphylococcus epidermidis — the dominant healthy skin commensal — produces serine protease Esp that inhibits S. aureus biofilm formation, produces bacteriocin-like molecules that kill S. aureus, and activates keratinocyte TLR-2 to induce endogenous antimicrobial peptides. The 2018 Science paper by Nakatsuji et al. demonstrated that specific S. epidermidis strains producing antimicrobial proteins dramatically reduced S. aureus colonization in clinical trials in atopic dermatitis — opening the field of microbiome therapeutics where targeted commensal reintroduction replaces broad-spectrum antibiotic killing.
Skin microbiome diversity is maintained by: avoiding excess soap (particularly antibacterial soaps that non-selectively kill commensals), avoiding unnecessary topical antibiotics, adequate skin hydration and barrier lipid support (ceramides, cholesterol, free fatty acids in appropriate ratios), and systemic gut microbiome health (the gut-skin immune communication ensures that gut microbiome interventions — dietary fiber, fermented foods, targeted probiotics — are reflected in cutaneous immune regulation). The “skin hygiene paradox” — that excessive hygiene destabilizes the commensal ecosystem that protects the skin — is now well-established and supports functional dermatology’s emphasis on microbiome preservation over antimicrobial assault.
Hormonal Skin Conditions: Perioral Dermatitis, Hair Loss, and Hormonal Acne
Perioral dermatitis — the papulopustular eruption around the mouth, nasal folds, and eyes disproportionately affecting women in their 20s-40s — is strongly associated with topical steroid use (including inhaled steroids spreading from adjacent skin) and, increasingly, with microbiome disruption from oral contraceptive use. OCPs alter the gut microbiome through estrogen enterohepatic recirculation, reduce zinc absorption, deplete folate, and alter sebum composition — all relevant to skin health. Zinc deficiency is mechanistically linked to perioral dermatitis: zinc is required for retinol-binding protein 2 (RBP2) that regulates vitamin A metabolism in keratinocytes. Zinc supplementation (30-45mg elemental zinc as picolinate or bisglycinate) combined with oral niacinamide and topical azelaic acid addresses multiple perioral dermatitis pathways.
Androgenetic alopecia (AGA) — the most common hair loss pattern — is driven by DHT sensitivity in genetically susceptible follicles on the vertex and frontal scalp. Elevated insulin from metabolic syndrome increases 5α-reductase activity, amplifying DHT production from testosterone. Insulin resistance-associated scalp inflammation (demonstrated by elevated scalp IL-1α and TNF-α in AGA compared to unaffected scalp skin) creates the microvascular inflammation preceding follicle miniaturization. Reducing insulin resistance, supporting adequate iron stores (ferritin below 50 ng/mL is associated with female pattern hair loss even without frank anemia — Rushton 1993), ensuring thyroid optimization (subclinical hypothyroidism being a major reversible cause of diffuse hair loss), and addressing nutritional cofactors (biotin, zinc, vitamin D, omega-3s, and adequate dietary protein) represent the functional approach that scalp-level treatments (minoxidil, finasteride) complement but cannot replace.
Functional Dermatology Protocol: Root-Cause Assessment and Treatment
Comprehensive Skin-Targeted Testing Panel
Root-cause skin assessment begins with systemic biomarkers that conventional dermatologists rarely order. Zinc (serum and RBC zinc — RBC zinc is a superior functional marker of intracellular zinc status, particularly relevant to acne and perioral dermatitis), ferritin (targeting above 50-70 ng/mL for hair health), vitamin D (targeting 60-70 ng/mL), comprehensive thyroid panel (TSH, free T4, free T3, reverse T3, and thyroid antibodies — subclinical hypothyroidism and Hashimoto’s both cause cutaneous manifestations from dry skin to hair loss), fasting insulin and HOMA-IR (elevated in hormonal acne, PCOS, and psoriasis), omega-3 index (below 8% in most acne and psoriasis patients), and comprehensive nutrient panel (GI-MAP or comprehensive stool analysis for gut microbiome assessment in psoriasis, atopic dermatitis, and SIBO-associated rosacea).
Evidence-Based Nutritional Interventions
Diet is the most upstream intervention for inflammatory skin disease. The low-glycemic diet — first demonstrated to improve acne in a 12-week RCT by Smith et al. (2007 American Journal of Clinical Nutrition, 43 participants) showing significant reduction in total lesion count, inflammatory lesions, and androgen levels — reduces mTORC1 activation, insulin/IGF-1 signaling, and sebum production. Dairy elimination (especially skim milk) removes acnegenic IGF-1, leucine, and hormonal precursors. Mediterranean diet pattern reduces psoriasis severity through combined omega-3 elevation, polyphenol anti-inflammatory effects, and microbiome diversity improvement. Elimination of common food sensitivities (gluten, dairy, eggs, nuts) under IgG testing guidance can identify idiosyncratic immune triggers in chronic atopic dermatitis or psoriasis patients not responding to standard care.
Targeted supplementation for skin conditions follows condition-specific evidence: Zinc picolinate 30-45 mg/day for acne (Dreno 2005 meta-analysis, though inferior to antibiotics, effective and non-antimicrobial), omega-3 EPA/DHA 3-4g/day for psoriasis and atopic dermatitis (anti-IL-17, anti-leukotriene mechanisms), vitamin D3 to 60-70 ng/mL for atopic dermatitis and psoriasis, niacinamide 500-1000mg/day (oral) or 4% topical for rosacea and acne (anti-inflammatory, sebum-regulating), evening primrose oil GLA 3-4g/day for atopic dermatitis (GLA converts to dihomo-GLA, a precursor to anti-inflammatory PGE1 that inhibits arachidonic acid release). Probiotics — particularly Lactobacillus rhamnosus GG, Lactobacillus acidophilus, and Bifidobacterium longum — have multiple randomized trials showing modest but significant atopic dermatitis improvement, particularly in pediatric populations.
Frequently Asked Questions: Functional Dermatology
Does diet really affect acne?
Yes — multiple randomized controlled trials now confirm the diet-acne connection. Smith et al. (2007) showed low-glycemic diet reduced acne lesion counts by 22% vs. high-glycemic diet at 12 weeks. Adebamowo’s 47,355-person NHS study confirmed dairy-acne associations. The mechanism — mTORC1 hyperactivation from high-glycemic foods, dairy IGF-1, and leucine — is well-characterized. For most patients with moderate-to-severe acne, eliminating dairy and high-glycemic foods (white bread, rice, sugar, processed grains) produces clinically meaningful improvement within 4-8 weeks. This does not mean diet alone clears severe acne — isotretinoin or combination therapy may still be appropriate — but dietary optimization is essential for long-term remission.
Can leaky gut cause psoriasis?
Evidence increasingly supports intestinal permeability as a co-driver of psoriasis. Psoriasis patients consistently show elevated serum zonulin (marker of intestinal permeability), reduced Akkermansia and Faecalibacterium in their gut microbiome, and elevated systemic inflammatory markers (TNF-α, IL-17, IL-23) consistent with gut-barrier-breached microbial stimulation. Gluten elimination benefits the psoriasis subgroup with elevated anti-gliadin antibodies (Michaelsson 2000 Lancet). Supporting gut barrier integrity — L-glutamine, zinc carnosine, butyrate supplementation, and fiber-rich diet supporting microbiome diversity — is a rational adjunctive treatment for psoriasis patients, particularly those with poor biologic response or concomitant GI symptoms.
What’s causing rosacea if not just bacteria?
Rosacea involves at least four co-contributing mechanisms: (1) Demodex folliculorum overgrowth releasing Bacillus oleronius that triggers TLR-2-mediated inflammation; (2) SIBO with gut-barrier LPS generating systemic endotoxemia reflected in facial vasoreactivity (Parodi 2008 — SIBO in 46% of rosacea patients, resolved with rifaximin); (3) Dysregulated cathelicidin/KLK5 innate immune pathway driving mast cell degranulation and neovascularization; (4) Neurovascular hypersensitivity (TRP channel sensitization) explaining flushing triggers. Effective functional treatment addresses all four: topical ivermectin for Demodex, SIBO treatment for gut-origin LPS, niacinamide/zinc for cathelicidin regulation, and trigger avoidance for neurovascular management.
What vitamins help eczema?
Several evidence-supported interventions for atopic dermatitis beyond topical steroids: Vitamin D3 to 60-70 ng/mL serum level (induces cathelicidin LL-37 reducing S. aureus colonization, promotes Treg differentiation away from Th2 skewing). Omega-3 EPA/DHA 3-4g/day (reduces IL-4, IL-13 — the Th2 cytokines driving IgE production and keratinocyte dysfunction). Evening primrose oil GLA 3-4g/day (anti-inflammatory PGE1 precursor). Probiotics — L. rhamnosus GG, B. longum — with strong pediatric evidence for prevention and modest treatment evidence. Zinc (RBC zinc deficiency impairs cathelicidin function and barrier repair). Quercetin 500-1000mg twice daily (mast cell stabilizer reducing histamine and IL-4 release). Addressing these nutritional deficiencies and supplementing evidence-based compounds complements standard moisturizer/emollient therapy.
Is zinc really effective for acne?
Zinc has multiple anti-acne mechanisms: it inhibits 5α-reductase (reducing DHT production in sebocytes), reduces TNF-α secretion from keratinocytes, inhibits Cutibacterium acnes biofilm formation, and is required for vitamin A metabolism critical for follicular epithelial differentiation. The 2005 Dreno meta-analysis of 17 zinc trials confirmed efficacy superior to placebo, though inferior to tetracycline antibiotics in head-to-head comparisons. The critical advantage: zinc is non-antimicrobial, does not contribute to antibiotic resistance, and unlike antibiotics actually addresses an upstream driver (DHT amplification, sebum quality) rather than just suppressing C. acnes. Optimal dosing: 30-45mg elemental zinc as picolinate or bisglycinate with food (to reduce GI effects); RBC zinc monitoring after 3 months to avoid overrepletion.
At The Private Practice, we approach chronic skin conditions by investigating the systemic and metabolic drivers that topical prescriptions do not address. Our evaluations include gut microbiome testing, comprehensive hormonal assessment, nutritional deficiency panels, and food sensitivity testing to identify the root-cause contributors to your skin disease. Many patients who have failed years of conventional dermatology experience dramatic improvement when the gut-skin axis, hormonal dysregulation, and nutritional deficiencies are systematically addressed. To schedule an evaluation, contact our office at (810) 206-1402.